Pine Bark Blood Pressure Meta-analysis: What the Evidence Says

Quick Answer

Pine Bark Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 preclinical study, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Procyanidins, flavonoids, and phenolic acids are among the concentrated forms of phenolic chemicals found in bark extracts, with antioxidant and antimicrobial properties. [Barros Diana (2025); evidence level 4]
• Growing public awareness is driving the quest for alternatives for currently undervalued forest leftovers and the application of alternative methods for the sustainable extraction of value-added substances found in these matrices. [Barros Diana (2025); evidence level 4]
• However, even in high-intensity training, which poses an increased risk for rhabdomyolysis compared to other exertive activities, CK levels rarely exceed 100,000 U/L. [Muacevic Alexander (2025); evidence level 4]
• At recommended dosages, pine bark extract has a favorable safety profile, with minimal side effects and no evidence of severe muscle toxicity, as supported by comprehensive systematic reviews and meta-analyses. [Muacevic Alexander (2025); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For pine bark blood pressure meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Barros Diana (2025). Correlation of Antioxidant and Antibacterial Activities of the Aqueous Pinus pinaster Aiton Bark Extract Within a Cytocompatible Concentration Range. DOI: 10.3390/antiox14111377. PMCID: PMC12649746. PMID: 41300533. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12649746/
• Muacevic Alexander (2025). Rhabdomyolysis Associated With Excess Pine Bark Extract: A Case Report. DOI: 10.7759/cureus.93956. PMCID: PMC12588601. PMID: 41200632. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12588601/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.